Please check your internet connection and try again.
# Cefexime
## Overview
- **Classification**: Third-generation cephalosporin antibiotic.
- **Mechanism**: Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to bacterial cell lysis.
## Primary Indications
1. **Acute Otitis Media (AOM)** - Treatment of bacterial ear infections.
2. **Pharyngitis/Tonsillitis** - Treatment of Streptococcus pyogenes infections.
3. **Acute Exacerbations of Chronic Bronchitis (AECB)** - Treatment of bacterial respiratory infections.
4. **Uncomplicated Gonorrhea** - Treatment of Neisseria gonorrhoeae infections.
5. **Uncomplicated Urinary Tract Infections (UTIs)** - Treatment of bacterial bladder/kidney infections.
## Adult Dosing
### Standard Dosing
**Acute Otitis Media, Pharyngitis/Tonsillitis, AECB, UTIs**
- **Dose**: **400 mg**
- **Frequency**: Once daily OR **200 mg** every 12 hours
- **Route**: Oral (PO)
- **Duration**: Typically 5-10 days, depending on infection.
**Uncomplicated Gonorrhea**
- **Dose**: **400 mg**
- **Frequency**: Single dose
- **Route**: Oral (PO)
- **Special Considerations**: Often co-administered with **1g azithromycin** PO single dose.
### Dose Adjustments
- **Renal Impairment**:
- CrCl 21-50 mL/min: **300 mg** PO daily.
- CrCl <20 mL/min (or on dialysis): **200 mg** PO daily.
- **Hepatic Impairment**: No specific dose adjustment needed.
- **Elderly Patients**: Adjust dose based on renal function, not age alone.
## Pediatric Dosing
### Neonates (0-28 days)
- **Dose**: Not generally recommended due to limited data.
- **Special Notes**: Use alternative agents or consult an infectious disease specialist.
### Infants (1-12 months)
- **Indication**: AOM, Pharyngitis/Tonsillitis, UTIs.
- **Dose**: **8 mg/kg**
- **Frequency**: Once daily OR **4 mg/kg** every 12 hours.
- **Maximum**: **400 mg/day**.
- **Formulation**: Oral suspension.
### Children (1-12 years)
- **Indication**: AOM, Pharyngitis/Tonsillitis, UTIs.
- **Dose**: **8 mg/kg**
- **Frequency**: Once daily OR **4 mg/kg** every 12 hours.
- **Maximum**: **400 mg/day**.
- **Formulation**: Oral suspension or chewable tablets.
### Adolescents (13-18 years)
- **Indication**: AOM, Pharyngitis/Tonsillitis, AECB, UTIs, Gonorrhea.
- **Dose**: Adult dosing applies. **400 mg** PO daily or **200 mg** PO every 12 hours.
- **Maximum**: **400 mg/day**.
## Safety Information
### Contraindications
- **Absolute**: Hypersensitivity to cefixime or other cephalosporins.
- **Absolute**: History of severe immediate hypersensitivity (e.g., anaphylaxis) to penicillins due to cross-reactivity risk.
### Common Adverse Effects
- **Very Common (>10%)**: Diarrhea (most frequent).
- **Common (1-10%)**: Nausea, abdominal pain, dyspepsia, headache, dizziness.
- **Serious but Rare**: Clostridioides difficile-associated diarrhea (CDAD), severe cutaneous reactions (e.g., SJS, TEN), anaphylaxis, hemolytic anemia, thrombocytopenia.
### Key Drug Interactions
- **Oral Anticoagulants (e.g., Warfarin)**: May enhance anticoagulant effect, increasing INR/bleeding risk. Monitor INR closely.
- **Carbamazepine**: May increase carbamazepine levels. Monitor carbamazepine levels if co-administered.
- **Probenecid**: May increase cefixime plasma concentrations. Not usually clinically significant.
## Monitoring & Follow-up
- **Before Treatment**: Assess renal function (CrCl) in patients with renal impairment or at risk.
- **During Treatment**: Monitor for resolution of infection symptoms.
- **During Treatment**: Monitor for adverse effects, especially diarrhea.
- **Clinical Signs**: Watch for severe or persistent diarrhea (possible CDAD), rash, signs of allergic reaction.
## Clinical Pearls
- 💡 **Tip 1**: Cefixime is an oral-only agent; there is no IV formulation.
- 💡 **Tip 2**: Convenient once or twice daily dosing improves patient adherence, especially in pediatrics.
- 💡 **Tip 3**: Can be taken with or without food; taking with food may reduce GI upset.
- 💡 **Tip 4**: Counsel patients to complete the entire course of therapy to prevent antibiotic resistance.
> **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.